Hemolytic Uremic Syndrome (HUS) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. coli Infection: a multinational embedded cluster crossover randomized trial (the HIKO STEC trial)
DiscussionHUS is a devastating illness with no treatment options. This pragmatic study will determine if hyperhydration can reduce morbidity associated with HUS in children with high-risk STEC infection.Trial registrationClinicalTrials.govNCT05219110. Registered on February 1, 2022. (Source: Trials)
Source: Trials - May 27, 2023 Category: Research Source Type: clinical trials

Eculizumab in Pediatric and Adult Participants With Atypical Hemolytic Uremic Syndrome (aHUS) in China
Condition: Atypical Hemolytic Uremic Intervention: Drug: Eculizumab Sponsors: Alexion; AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 25, 2023 Category: Research Source Type: clinical trials

Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic Syndrome
Condition: Hypertensive Emergency-associated Hemolytic Uremic Syndrome Interventions: Drug: Soliris®; Drug: Renin angiotensin system blockers Sponsor: Assistance Publique - Hôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2023 Category: Research Source Type: clinical trials